Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
09/2010
09/30/2010WO2010065671A3 Treatment of vascular endothelial growth factor (vegf) related diseases by inhibition of natural antisense transcript to vegf
09/30/2010WO2009127949A8 4- [3- (aryloxy) benzylidene] -3-methyl piperidine aryl carboxamide compounds useful as faah inhibitors
09/30/2010US20100249459 Formoterol Tartrate Process and Polymorph
09/30/2010US20100249248 LIGAND AGENTS FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPARs)
09/30/2010US20100249243 Novel beta-hydroxyketones and beta-alkoxyketones with estrogenic activity
09/30/2010US20100249207 Synthesis of pyrrolidine compounds
09/30/2010US20100249206 Modified lysine-mimetic compounds
09/30/2010US20100249204 Calcium salts of indole derived statins
09/30/2010US20100249192 Novel heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
09/30/2010US20100249189 Nitric oxide donor compounds
09/30/2010US20100249174 Ccr1 antagonists and methods of use therefor
09/30/2010US20100249165 Pdz domain modulators
09/30/2010US20100249163 Renin inhibitors
09/30/2010US20100249161 2- ( 2 -hydroxyphenyl) -quinazolin-4-ones useful for treating obesity and diabetes
09/30/2010US20100249159 Rho-kinase inhibitors
09/30/2010US20100249149 Inhibitors of Protein Kinases
09/30/2010US20100249148 Novel pyrimidine compounds having benzyl (heterocyclic methyl) amine structure and medicament comprising the same
09/30/2010US20100249137 Novel sEH Inhibitors and Their Use
09/30/2010US20100249131 Morpholino pyrimidine derivatives used in diseases linked to mtor kinase and/or pi3k
09/30/2010US20100249129 Compounds as cannabinoid receptor ligands
09/30/2010US20100249128 Novel 3-amido-pyrrolo[3,4-c]pyrazole-5(1h,4h,6h) carbaldehyde derivatives
09/30/2010US20100249124 2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds
09/30/2010US20100249118 Compounds and methods for kinase modulation, and indications therefor
09/30/2010US20100249117 Factor xa inhibitors
09/30/2010US20100249113 Modulators of atp binding cassette transporters
09/30/2010US20100249104 Methods for using vasopressin antagonists with anthracycline chemotherapy agents to reduce cardiotoxicity and/or improve survival
09/30/2010US20100249103 combination treatment
09/30/2010US20100249102 Heterotricyclic Metalloprotease Inhibitors
09/30/2010US20100249101 Malonamide derivatives with antithrombotic activity
09/30/2010US20100249098 Oxypiperidine derivatives and methods of use thereof
09/30/2010US20100249085 Heteroaryl substituted pyrazole derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
09/30/2010US20100249082 Modulators of hypoxia inducible factor-1 and related uses
09/30/2010US20100249081 Compositions and methods for treatment of renal disease
09/30/2010US20100249079 Analogues of cilostazol
09/30/2010US20100249078 Tetracyclic inhibitors of fatty acid amide hydrolase
09/30/2010US20100249074 Benzyl-cycloalkyl sphingosine 1-phosphate receptor modulators
09/30/2010US20100249064 Methods and compositions for treating diseases and conditions involving higher molecular weight hyaluronan
09/30/2010US20100249035 Peptides, compositions and uses thereof
09/30/2010US20100249034 Gfralpha3 and its uses
09/30/2010US20100249032 Human EPO Mimetic Hinge Core Mimetibodies, Compositions, Methods and Uses
09/30/2010US20100249024 Cetp inhibitors
09/30/2010US20100249023 Isoflavone formulation
09/30/2010US20100249019 Use of a peptide as a therapeutic agent
09/30/2010US20100249017 Use of cnp-22, alone or in combination with physalemin, as a therapeutic agent
09/30/2010US20100249016 Metal-binding compounds and uses therefor
09/30/2010US20100247691 Anti-angiogenic agents and anti-obesity substances applied with anti-angiogenesis from natural products
09/30/2010US20100247688 Pirenzepine and derivatives thereof as anti-amyloid agents
09/30/2010US20100247682 Use of nitrite salts for the treatment of cardiovascular conditions
09/30/2010US20100247680 Compositions and Methods to Modulate Angiogenesis
09/30/2010US20100247668 Polymer-agent conjugates, particles, compositions, and related methods of use
09/30/2010US20100247649 Pharmaceutical formulations comprising telmisartan and hydrochlorothiazide
09/30/2010US20100247646 Extended release tablets of nisoldipine
09/30/2010US20100247645 Pharmaceutical combination of aliskiren and valsartan
09/30/2010US20100247636 Nanoparticulate and controlled release compositions comprising nilvadipine
09/30/2010US20100247603 Arsenic trioxide medical elution scaffold
09/30/2010US20100247602 Method of reducing the effects of cytostatic drugs on bone marrow derived cells, and methods of screening
09/30/2010US20100247577 Tr1 cells, mesenchymal stem cells and uses thereof
09/30/2010US20100247534 Fused heterocyclic compounds as inhibitors of potassium channel function
09/30/2010US20100247520 Mutated netrin 4, fragments thereof and uses thereof as drugs
09/30/2010US20100247518 Modified proteins, designer toxins, and methods of making thereof
09/30/2010US20100247516 Compositions comprising semaphorins for the treatment of angiogenesis related diseases and methods of selection thereof
09/30/2010US20100247514 Gamma secretase modulators
09/30/2010US20100247511 Methods and compositions for activated protein c with reduced anticoagulant properties
09/30/2010US20100247510 agent for reducing a side effect of an anticancer drug
09/30/2010US20100247506 Formation of stable submicron peptide or protein particles by thin film freezing
09/30/2010US20100247505 Composition for Reducing the Level of Glucose, Malondialdehyde-Modified LDL, Homocysteine and/or C-Reactive Protein in Blood
09/30/2010US20100247493 Method for Identifying and Selecting Cardiomyocytes
09/30/2010US20100247482 Tight junction modulator peptides for enhanced mucosal delivery of therapeutic compounds
09/30/2010US20100247468 Compounds that modulate PPAR gamma-type receptors and cosmetic/pharmaceutical compositions comprising said compounds
09/30/2010US20100247452 Use of erythropoietin
09/30/2010US20100247451 Use of erythropoietin
09/30/2010US20100247450 Use of erythropoietin
09/30/2010US20100247447 Drug delivery system for hydrophobic drugs
09/30/2010US20100247439 Dendritic nano-antioxidants
09/30/2010DE102009014484A1 Substituierte Piperidine Substituted piperidines
09/30/2010CA2756941A1 Compositions and methods for treatment of hemorrhage
09/30/2010CA2756786A1 Methods for preventing major adverse cardiovascular events with dpp-iv inhibitors
09/30/2010CA2754416A1 Novel medicament for treating cognitive impairment
09/29/2010EP2233561A1 Method for amplification of hematopoietic stem cell using heterocyclic compound
09/29/2010EP2233498A1 Kallikrein-inhibiting Kunitz Domain proteins and nucleic acids encoding the same
09/29/2010EP2233495A1 Glycosylated glycopeptide antibiotic derivative
09/29/2010EP2233486A1 Azaindoles
09/29/2010EP2233483A1 Indole or Benzimidazole derivatives as IkB-kinase modulators and intermediates in their preparation.
09/29/2010EP2233145A1 A dose of AVE5026 for the treatment of venous thromboembolism in patients with severe renal impairment
09/29/2010EP2231677A2 Trisubstituted piperidines as renin inhibitors
09/29/2010EP2231666A1 Carboxamide, sulfonamide and amine compounds for metabolic disorders
09/29/2010EP2231660A1 Imidazo [1,2-a] pyridine compounds
09/29/2010EP2231648A1 New salts and crystal forms
09/29/2010EP2231645A2 5-halogen-substituted oxindole derivatives and use thereof for treating vasopressine-dependent diseases
09/29/2010EP2231644A2 5,6-disubstituted oxindole-derivatives and use thereof for treating vasopressine-dependent diseases
09/29/2010EP2231643A1 Amidomethyl-substituted oxindole derivatives and the use thereof for the treatment of vasopressin-dependent illnesses
09/29/2010EP2231600A1 Carboxamide, sulfonamide and amine compounds for metabolic disorders
09/29/2010EP2231164A1 Oxysterols for activation of hedgehog signaling, osteoinduction, antiadipogenesis, and wnt signaling
09/29/2010EP2231157A1 Methods for increasing endothelial progentior cells
09/29/2010EP2231137A1 Method of modulating membrane potential of a cell
09/29/2010EP1940409B1 Novel pharmaceutical combinations for the treatment of respiratory disorders
09/29/2010EP1768979B1 Octahydropyrrolo[2, 3, c]pyridine derivatives and pharmaceutical use thereof
09/29/2010EP1638548B1 Preventing atrial fibrillation (af) with the use of statin drugs
09/29/2010EP1569953B1 Peptide gap junction modulators
09/29/2010EP1095274B1 Trifunctional reagent for conjugation to a biomolecule
1 ... 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 ... 1595